The current study has indicated that miR-200c is a tumor-suppressive miRNA in bladder cancer, and that oncogene and transcription promoters, namely, BMI-1 and E2F3, are functional targets of miR-200c. The gene discussed is E2F3; the disease is urinary bladder cancer.